Skip to main content
Home
News
Live
Companies
Pricing
About Us
Language
...
Sign In
Register
Back to News
Tag: #Alzheimer’s disease
3 articles
Title
Company
Published
OpenAI Foundation pledges $100 million to accelerate Alzheimer’s research with AI
#Alzheimer’s disease
#Artificial intelligence
#Research funding
#Drug repurposing
#OpenAI Foundation
Tervion
May 3, 2026
FDA approves Auvelity for agitation associated with dementia due to Alzheimer’s disease
#FDA approval
#Alzheimer’s disease
#Axsome Therapeutics
#Auvelity
#Neuropsychiatry
Tervion
May 1, 2026
Cochrane review: Anti-amyloid Alzheimer’s drugs show no meaningful clinical benefit
#Alzheimer’s disease
#Cochrane review
#beta-amyloid
#clinical trials
#drug safety
Tervion
Apr 17, 2026
#Alzheimer’s disease News | Tervion
